サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654683

世界の二重エネルギーX線吸収測定市場-2025-2033年

Global Dual Energy X-Ray Absorptiometry Market - 2025-2033

出版日
ページ情報
英文 157 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
世界の二重エネルギーX線吸収測定市場-2025-2033年
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 157 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の二重エネルギーX線吸収測定（DEXA）市場は、2024年に2億5,290万米ドルに達し、2033年には3億8,750万米ドルに達すると予測され、予測期間2025-2033年のCAGRは4.9%で成長すると予測されています。

二重エネルギーX線吸収測定法（DEXA）は、主に骨密度（BMD）と体組成の評価に使用される非侵襲的医療画像技術です。DEXAは、2つの異なるエネルギーレベルのX線が体内を通過する際の吸収を測定することで機能します。この方法により、X線の吸収の仕方に基づいて骨組織と軟部組織（筋肉や脂肪など）を正確に区別することができます。このシステムでは、エネルギーレベルの異なる2つのX線ビームを使用して身体をスキャンします。2つのエネルギーレベルの吸収の違いにより、骨密度と軟部組織の組成を正確に測定することができます。

二重エネルギーX線吸収測定法（DEXA）の市場需要は、ヘルスケア、特に骨の健康、体組成分析、骨粗鬆症管理の分野におけるさまざまな世界の動向とニーズによって形成されています。例えば、Bone Health &Osteoporosis Foundationによると、米国では約1,000万人が骨粗鬆症であり、推定4,400万人が低骨密度（骨減少症）であり、人口の高齢化に伴って増加すると予測されています。骨粗鬆症は高齢者の骨折の主な原因のひとつです。世界人口の高齢化に伴い、骨粗鬆症スクリーニングのためのDEXAスキャンに対する需要は大幅に増加しています。

市場力学：

促進要因と抑制要因

骨粗鬆症と骨障害の有病率の上昇

骨粗鬆症と骨疾患の有病率の上昇は、二重エネルギーX線吸収測定（DEXA）市場の成長を著しく促進しており、予測期間中も市場を牽引すると予想されます。骨粗鬆症は、骨密度（BMD）の低下を特徴とし、骨が弱くなり骨折のリスクが高まります。骨粗鬆症は特に高齢者、特に閉経後の女性に多く見られます。

例えば、国際骨粗鬆症財団（IOF）によると、50歳以上の女性の約3人に1人、男性の約5人に1人が生涯に骨粗鬆症性骨折を経験するとされています。さらに、Bone Health &Osteoporosis Foundationによると、米国では約1,000万人が骨粗鬆症に罹患しており、さらに4,400万人が骨密度の低下によるリスクを抱えています。このような幅広い有病率は、早期発見と定期的なスクリーニングの必要性を強調し、DEXAの需要を高めています。

世界的に人口が高齢化するにつれて、骨の健康診断に対する需要は増加します。世界保健機関（WHO）によると、2050年までに60歳以上の人口は20億人を超えると予想されており、このグループの多くが骨粗鬆症のリスクを抱えています。高齢者は骨減少症や骨粗鬆症などの骨の健康問題を発症する可能性が高く、早期診断とモニタリングのためのDEXAスキャンへの需要を促進しています。

DEXA装置の高コスト

DEXA装置の高価格は、二重エネルギーX線吸収測定（DEXA）市場の成長にとって大きな障壁です。DEXA装置の価格は、モデル、機能、ブランドによって異なるが、通常2万米ドルから10万米ドル以上です。このような高額な初期投資は、小規模ヘルスケア施設、地方の診療所、低所得地域の病院がこのような機器を購入することを困難にしています。特に医療資金が限られている地域や、骨密度スクリーニングがまだ普及していない地域では、小規模の診療所やプライマリケア診療所では、DEXA装置に投資することは経済的に不可能と思われるかもしれないです。

初期購入価格は別として、運用コスト（電気代、スタッフ教育、定期的なメンテナンスなど）が負担になります。DEXA装置の維持には熟練した人材、専門的な校正、定期的な整備が必要であり、ヘルスケア提供者の運営経費をさらに増大させる。例えば、低・中所得国（LMICs）のヘルスケアセンターでは、メンテナンスの必要性を維持するのに苦労することがあり、DEXA装置の利用不足や故障につながります。

DEXA装置は高価であるため、超音波ベースの骨密度計や定量的コンピュータ断層撮影（QCT）のような代替技術に有利です。例えば、超音波ベースの装置はより手頃な価格で（価格はしばしば1万米ドル以下）、放射線を使用しない代替手段を提供するため、予算に余裕のないヘルスケアプロバイダーにとって魅力的な選択肢となります。

目次

第1章 市場イントロダクションと範囲

  • 報告書の目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • 製品タイプ別のスニペット
  • 移植性によるスニペット
  • 用途別スニペット
  • 最終用途による抜粋
  • 地域別スニペット

第3章 市場力学

  • 影響要因
    • 促進要因
      • 骨粗鬆症および骨疾患の罹患率の上昇
    • 抑制要因
      • DEXA装置の高コスト
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名なプレーヤー
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • 新興スタートアップ企業と主要イノベーター
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学

第5章 二重エネルギーX線吸収測定（DEXA）市場、製品タイプ別

  • 中央二重エネルギーX線吸収測定
  • 周辺機器二重エネルギーX線吸収測定

第6章 二重エネルギーX線吸収測定（DEXA）市場、ポータビリティ別

  • スタンドアロン
  • ポータブル

第7章 二重エネルギーX線吸収測定（DEXA）市場、用途別

  • 骨密度測定
  • 骨粗鬆症
  • 骨折管理
  • その他

第8章 二重エネルギーX線吸収測定（DEXA）市場、最終用途別

  • 病院
  • 専門クリニック
  • 診断センター
  • その他

第9章 二重エネルギーX線吸収測定（DEXA）市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場プレーヤー
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • GE HealthCare
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • Hologic, Inc.
  • OSTEOSYS Corp.
  • DMS Group
  • Swissray International, Inc.
  • Xuzhou Pinyuan Electronic Technology Co., Ltd.
  • FUJIFILM Holdings Corporation
  • Scintica Instrumentation, Inc.
  • IDETEC MEDICAL IMAGING
  • Trivitron Healthcare

第12章 仮定と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証と検証

第13章 付録

目次
Product Code: MD7679

The global Dual Energy X-Ray Absorptiometry (DEXA) market reached US$ 252.9 million in 2024 and is expected to reach US$ 387.5 million by 2033, growing at a CAGR of 4.9% during the forecast period 2025-2033.

Dual-Energy X-Ray Absorptiometry (DEXA) is a non-invasive medical imaging technique used primarily for assessing bone mineral density (BMD) and body composition. It works by measuring the absorption of X-rays at two different energy levels as they pass through the body. This method allows for precise differentiation between bone tissue and soft tissue (such as muscle and fat) based on how they absorb X-rays. The system uses two X-ray beams with different energy levels to scan the body. The difference in absorption between the two energy levels allows for accurate measurement of bone density and soft tissue composition.

The market demand for Dual-Energy X-Ray Absorptiometry (DEXA) is shaped by various global trends and needs in healthcare, particularly in the fields of bone health, body composition analysis and osteoporosis management. For instance, according to the Bone Health & Osteoporosis Foundation, in the U.S., approximately 10 million people have osteoporosis, and an estimated 44 million people have low bone density (osteopenia), with a projected increase as the population ages. Osteoporosis is one of the leading causes of bone fractures among the elderly. As the global population ages, the demand for DEXA scans for osteoporosis screening has significantly increased.

Market Dynamics: Drivers & Restraints

Rising prevalence of osteoporosis and bone disorders

The rising prevalence of osteoporosis and bone disorders is significantly driving the growth of the Dual Energy X-Ray Absorptiometry (DEXA) market and is expected to drive the market over the forecast period. Osteoporosis, characterized by reduced bone mineral density (BMD), leads to weaker bones and an increased risk of fractures. It is especially common among elderly populations, particularly post-menopausal women.

For instance, according to the International Osteoporosis Foundation (IOF), approximately 1 in 3 women over the age of 50 years and 1 in 5 men will experience osteoporotic fractures in their lifetime. Moreover, according to the Bone Health & Osteoporosis Foundation, in the United States, nearly 10 million people suffer from osteoporosis, and an additional 44 million are at risk due to low bone density. This wide prevalence underscores the need for early detection and regular screening, which boosts the DEXA demand.

As populations age globally, the demand for bone health screening increases. By 2050, the number of people aged 60 and older is expected to rise to over 2 billion according to the World Health Organization, with many in this group at risk of osteoporosis. Elderly individuals are more likely to develop bone health issues such as osteopenia or osteoporosis, driving the demand for DEXA scans for early diagnosis and monitoring.

High cost of the DEXA devices

The high cost of DEXA devices is a significant barrier to the growth of the Dual-Energy X-Ray Absorptiometry (DEXA) market. The price of a DEXA machine typically ranges from $20,000 to over $100,000, depending on the model, features, and brand. This steep initial investment makes it difficult for smaller healthcare facilities, rural clinics, and hospitals in low-income regions to afford such equipment. Small clinics and primary care practices may find it financially unfeasible to invest in DEXA machines, especially in regions with limited healthcare funding or where bone density screening is not yet a widespread practice.

Aside from the initial purchase price, operational costs (such as electricity, staff training, and regular maintenance) add to the burden. Maintaining a DEXA machine requires skilled personnel, specialized calibration, and periodic servicing, which further increases operational expenses for healthcare providers. For instance, healthcare centers in low- and middle-income countries (LMICs) may struggle to keep up with maintenance requirements, which leads to underutilization or failure of DEXA equipment.

The high cost of DEXA machines also gives an advantage to alternative technologies such as ultrasound-based bone densitometers or quantitative computed tomography (QCT), which are less expensive and increasingly used for screening. For instance, ultrasound-based devices are more affordable (with prices often under $10,000) and offer a radiation-free alternative, making them an attractive option for healthcare providers on a budget.

Segment Analysis

The global Dual Energy X-Ray Absorptiometry (DEXA) market is segmented based on product type, portability, application, end-user and region.

Product Type:

The central dual energy x-ray absorptiometry segment is expected to dominate the Dual Energy X-Ray Absorptiometry (DEXA) market share

Central DEXA scans are considered the gold standard for bone mineral density (BMD) measurement, as they provide highly accurate and reproducible results compared to peripheral DEXA or other diagnostic methods. The spine and hip are the primary sites where bone loss occurs, and measuring BMD in these regions offers a reliable assessment of fracture risk. For instance, the International Osteoporosis Foundation (IOF) and National Osteoporosis Foundation (NOF) strongly endorse central DEXA scanning for the early detection of osteoporosis and its progression, making it the most trusted and widely used method in clinical practice.

Central DEXA is widely used in osteoporosis management, as it helps in risk stratification by measuring the bone density of high-risk areas like the spine and hip, where fractures due to osteoporosis are most common. The central segment also plays a significant role in assessing fracture risk and determining the effectiveness of osteoporosis treatments like bisphosphonates, denosumab, or teriparatide. The ability to track changes in BMD over time is critical for tailoring treatment plans.

Geographical Analysis

North America is expected to hold a significant position in the Dual Energy X-Ray Absorptiometry (DEXA) market share

Osteoporosis is a significant health concern in North America especially in the United States, particularly among the elderly population, which drives the demand for bone density screenings and diagnostic tools like DEXA. According to the National Osteoporosis Foundation (NOF), around 10 million people in the U.S. suffer from osteoporosis, and an estimated 44 million people have low bone density (osteopenia), putting them at risk for fractures. This high prevalence of bone disorders significantly contributes to the demand for DEXA scans as the gold standard for diagnosing osteoporosis and assessing fracture risk.

In North America, there is a strong focus on preventive healthcare, and the general population is becoming more aware of the risks of osteoporosis and other bone-related disorders. Organizations like the National Osteoporosis Foundation (NOF) and American Bone Health run continuous public awareness campaigns to educate people about the importance of bone density testing. These initiatives encourage individuals to undergo routine DEXA screenings, thus driving demand for DEXA devices.

North America, particularly the United States and Canada, has some of the most advanced healthcare systems globally. With a high number of hospitals, clinics and specialty centers dedicated to bone health and osteoporosis management, the region has easy access to advanced diagnostic tools like DEXA machines. The U.S. healthcare system is characterized by an extensive network of diagnostic imaging centers, many of which offer DEXA scans as part of routine check-ups, contributing to high market penetration.

Asia-Pacific is growing at the fastest pace in the Dual Energy X-Ray Absorptiometry (DEXA) market

The Asia-Pacific region is home to some of the fastest-aging populations globally. For instance, Japan, China, and India are witnessing a rapid increase in their elderly populations. According to the United Nations, by 2050, the number of people aged 60 years and older in Asia will more than double to 1.3 billion. Osteoporosis and bone health issues become more prevalent with age, making bone density testing a critical part of healthcare in this demographic. The aging population in APAC increases the demand for DEXA scans for osteoporosis detection and fracture risk assessment.

The prevalence of osteoporosis is rising rapidly in many Asia-Pacific countries due to factors such as lifestyle changes, dietary habits and sedentary living. Countries like China and India, despite being home to large populations, have relatively low awareness of osteoporosis, which is leading to an increase in undiagnosed cases. According to the National Institute of Health (NIH), China and India together account for approximately 50% of the world's osteoporotic fractures. As awareness grows about the importance of bone health, the demand for DEXA scans for early diagnosis is increasing.

Competitive Landscape

The major global players in the Dual Energy X-Ray Absorptiometry (DEXA) market include GE HealthCare, Hologic, Inc., OSTEOSYS Corp., DMS Group, Swissray International, Inc., Xuzhou Pinyuan Electronic Technology Co., Ltd., FUJIFILM Holdings Corporation, Scintica Instrumentation, Inc., IDETEC MEDICAL IMAGING, Trivitron Healthcare and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Dual Energy X-Ray Absorptiometry (DEXA) market report delivers a detailed analysis with 70 key tables, more than 62 visually impactful figures, and 157 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Portability
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Osteoporosis and Bone Disorders
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of DEXA Devices
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Dual Energy X-Ray Absorptiometry (DEXA) Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Central Dual Energy X-ray Absorptiometry*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Peripheral Dual Energy X-ray Absorptiometry

6. Dual Energy X-Ray Absorptiometry (DEXA) Market, By Portability

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 6.1.2. Market Attractiveness Index, By Portability
  • 6.2. Standalone*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Portable

7. Dual Energy X-Ray Absorptiometry (DEXA) Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Bone Densitometry*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Osteoporosis
  • 7.4. Fracture Management
  • 7.5. Others

8. Dual Energy X-Ray Absorptiometry (DEXA) Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Diagnostic Centers
  • 8.5. Others

9. Dual Energy X-Ray Absorptiometry (DEXA) Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. GE HealthCare*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Hologic, Inc.
  • 11.3. OSTEOSYS Corp.
  • 11.4. DMS Group
  • 11.5. Swissray International, Inc.
  • 11.6. Xuzhou Pinyuan Electronic Technology Co., Ltd.
  • 11.7. FUJIFILM Holdings Corporation
  • 11.8. Scintica Instrumentation, Inc.
  • 11.9. IDETEC MEDICAL IMAGING
  • 11.10. Trivitron Healthcare

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us